|
1
|
Ralapanawa U and Sivakanesan R:
Epidemiology and the magnitude of coronary artery disease and acute
coronary syndrome: A narrative review. J Epidemiol Glob Health.
11:169–177. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pagliaro BR, Cannata F, Stefanini GG and
Bolognese L: Myocardial ischemia and coronary disease in heart
failure. Heart Fail Rev. 25:53–65. 2020. View Article : Google Scholar
|
|
3
|
Horowitz LN, Harken AH, Josephson ME and
Kastor JA: Surgical treatment of ventricular arrhythmias in
coronary artery disease. Ann Intern Med. 95:88–97. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sara JD, Eleid MF, Gulati R and Holmes DR
Jr: Sudden cardiac death from the perspective of coronary artery
disease. Mayo Clin Proc. 89:1685–1698. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Russell MW, Huse DM, Drowns S, Hamel EC
and Hartz SC: Direct medical costs of coronary artery disease in
the United States. Am J Cardiol. 81:1110–1115. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ference BA, Yoo W, Alesh I, Mahajan N,
Mirowska KK, Mewada A, Kahn J, Afonso L, Williams KA Sr and Flack
JM: Effect of long-term exposure to lower low-density lipoprotein
cholesterol beginning early in life on the risk of coronary heart
disease: A Mendelian randomization analysis. J Am Coll Cardiol.
60:2631–2639. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Toth PP: High-density lipoprotein and
cardiovascular risk. Circulation. 109:1809–1812. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gallo G, Volpe M and Savoia C: Endothelial
dysfunction in hypertension: Current concepts and clinical
implications. Front Med (Lausanne). 8:7989582022. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yang DR, Wang MY, Zhang CL and Wang Y:
Endothelial dysfunction in vascular complications of diabetes: A
comprehensive review of mechanisms and implications. Front
Endocrinol (Lausanne). 15:13592552024. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Alpert JS: New coronary heart disease risk
factors. Am J Med. 136:331–332. 2023. View Article : Google Scholar
|
|
11
|
Malakar AK, Choudhury D, Halder B, Paul P,
Uddin A and Chakraborty S: A review on coronary artery disease, its
risk factors, and therapeutics. J Cell Physiol. 234:16812–16823.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nettleship J, Jones R, Channer K and Jones
T: Testosterone and coronary artery disease. Front Horm Res.
37:91–107. 2009. View Article : Google Scholar
|
|
13
|
Bauersachs R, Zeymer U, Brière JB, Marre
C, Bowrin K and Huelsebeck M: Burden of coronary artery disease and
peripheral artery disease: A literature review. Cardiovasc Ther.
2019:82950542019. View Article : Google Scholar
|
|
14
|
Lee YTH, Fang J, Schieb L, Park S, Casper
M and Gillespie C: Prevalence and trends of coronary heart disease
in the United States, 2011 to 2018. JAMA Cardiol. 7:459–462. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Libby P and Theroux P: Pathophysiology of
coronary artery disease. Circulation. 111:3481–3488. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Weber C and Noels H: Atherosclerosis:
Current pathogenesis and therapeutic options. Nat Med.
17:1410–1422. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Attiq A, Afzal S, Ahmad W and Kandeel M:
Hegemony of inflammation in atherosclerosis and coronary artery
disease. Eur J Pharmacol. 966:1763382024. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen Y, Yu Y, Zou W, Zhang M, Wang Y and
Gu Y: Association between cardiac autonomic nervous dysfunction and
the severity of coronary lesions in patients with stable coronary
artery disease. J Int Med Res. 46:3729–3740. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Parisi AF, Folland ED and Hartigan P: A
comparison of angioplasty with medical therapy in the treatment of
single-vessel coronary artery disease. Veterans affairs ACME
investigators. N Engl J Med. 326:10–16. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Velazquez EJ, Lee KL, Jones RH, Al-Khalidi
HR, Hill JA, Panza JA, Michler RE, Bonow RO, Doenst T, Petrie MC,
et al: Coronary-artery bypass surgery in patients with ischemic
cardiomyopathy. N Engl J Med. 374:1511–1520. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Del Buono MG, Montone RA, Camilli M,
Carbone S, Narula J, Lavie CJ, Niccoli G and Crea F: Coronary
microvascular dysfunction across the spectrum of cardiovascular
diseases: JACC state-of-the-art review. J Am Coll Cardiol.
78:1352–1371. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Silvani A, Calandra-Buonaura G, Dampney
RAL and Cortelli P: Brain-heart interactions: Physiology and
clinical implications. Philos Trans A Math Phys Eng Sci.
374:201501812016.PubMed/NCBI
|
|
23
|
Wehrwein EA, Orer HS and Barman SM:
Overview of the anatomy, physiology, and pharmacology of the
autonomic nervous system. Compr Physiol. 6:1239–1278. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Silva LEV, Silva CAA, Salgado HC and Fazan
R Jr: The role of sympathetic and vagal cardiac control on
complexity of heart rate dynamics. Am J Physiol Heart Circ Physiol.
312:H469–H477. 2017. View Article : Google Scholar
|
|
25
|
Charkoudian N and Rabbitts JA: Sympathetic
neural mechanisms in human cardiovascular health and disease. Mayo
Clin Proc. 84:822–830. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kasahara Y, Yoshida C, Saito M and Kimura
Y: Assessments of heart rate and sympathetic and parasympathetic
nervous activities of normal mouse fetuses at different stages of
fetal development using fetal electrocardiography. Front Physiol.
12:6528282021. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Curtis BM and O'Keefe JH Jr: Autonomic
tone as a cardiovascular risk factor: The dangers of chronic fight
or flight. Mayo Clin Proc. 77:45–54. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Brunner-La Rocca HP, Esler MD, Jennings GL
and Kaye DM: Effect of cardiac sympathetic nervous activity on mode
of death in congestive heart failure. Eur Heart J. 22:1136–1143.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hadaya J and Ardell JL: Autonomic
modulation for cardiovascular disease. Front Physiol.
11:6174592020. View Article : Google Scholar
|
|
30
|
Shen MJ and Zipes DP: Role of the
autonomic nervous system in modulating cardiac arrhythmias. Circ
Res. 114:1004–1021. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Malpas SC: Sympathetic nervous system
overactivity and its role in the development of cardiovascular
disease. Physiol Rev. 90:513–557. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Grassi G and Drager LF: Sympathetic
overactivity, hypertension and cardiovascular disease: State of the
art. Curr Med Res Opin. 40(Suppl 1): S5–S13. 2024. View Article : Google Scholar
|
|
33
|
Bazoukis G, Stavrakis S and Armoundas AA:
Vagus nerve stimulation and inflammation in cardiovascular disease:
A state-of-the-art review. J Am Heart Assoc. 12:e0305392023.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Capilupi MJ, Kerath SM and Becker LB:
Vagus nerve stimulation and the cardiovascular system. Cold Spring
Harb Perspect Med. 10:a0341732020. View Article : Google Scholar
|
|
35
|
De Ferrari GM and Schwartz PJ: Vagus nerve
stimulation: from pre-clinical to clinical application: Challenges
and future directions. Heart Fail Rev. 16:195–203. 2011. View Article : Google Scholar
|
|
36
|
Deer TR, Levy RM, Kramer J, Poree L,
Amirdelfan K, Grigsby E, Staats P, Burton AW, Burgher AH, Obray J,
et al: Dorsal root ganglion stimulation yielded higher treatment
success rate for complex regional pain syndrome and causalgia at 3
and 12 months: A randomized comparative trial. Pain. 158:669–681.
2017. View Article : Google Scholar :
|
|
37
|
Bernstein SA, Wong B, Vasquez C, Rosenberg
SP, Rooke R, Kuznekoff LM, Lader JM, Mahoney VM, Budylin T,
Älvstrand M, et al: Spinal cord stimulation protects against atrial
fibrillation induced by tachypacing. Heart Rhythm. 9:1426–1433.e3.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Torre-Amione G, Alo K, Estep JD,
Valderrabano M, Khalil N, Farazi TG, Rosenberg SP, Ness L and Gill
J: Spinal cord stimulation is safe and feasible in patients with
advanced heart failure: Early clinical experience. Eur J Heart
Fail. 16:788–795. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Cucinotta F, Swinnen B, Makovac E,
Hirschbichler S, Pereira E, Little S, Morgante F and Ricciardi L:
Short term cardiovascular symptoms improvement after deep brain
stimulation in patients with Parkinson's disease: A systematic
review. J Neurol. 271:3764–3776. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Clancy JA, Johnson R, Raw R, Deuchars SA
and Deuchars J: Anodal transcranial direct current stimulation
(tDCS) over the motor cortex increases sympathetic nerve activity.
Brain Stimul. 7:97–104. 2014. View Article : Google Scholar
|
|
41
|
Lee H, Lee JH, Hwang MH and Kang N:
Repetitive transcranial magnetic stimulation improves
cardiovascular autonomic nervous system control: A meta-analysis. J
Affect Disord. 339:443–453. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
De Decker K, Beese U, Staal MJ and
Dejongste MJL: Electrical neuromodulation for patients with cardiac
diseases. Neth Heart J. 21:91–94. 2013. View Article : Google Scholar :
|
|
43
|
Zipes DP, Neuzil P, Theres H, Caraway D,
Mann DL, Mannheimer C, Van Buren P, Linde C, Linderoth B, Kueffer
F, et al: Determining the feasibility of spinal cord
neuromodulation for the treatment of chronic systolic heart
failure: The DEFEAT-HF study. JACC Heart Fail. 4:129–136. 2016.
View Article : Google Scholar
|
|
44
|
Rodrigues B, Barboza CA, Moura EG,
Ministro G, Ferreira-Melo SE, Castaño JB, Nunes WMS, Mostarda C,
Coca A, Vianna LC and Moreno-Junior H: Acute and short-term
autonomic and hemodynamic responses to transcranial direct current
stimulation in patients with resistant hypertension. Front
Cardiovasc Med. 9:8534272022. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Imran TF, Malapero R, Qavi AH, Hasan Z, de
la Torre B, Patel YR, Yong RJ, Djousse L, Gaziano JM and
Gerhard-Herman MD: Efficacy of spinal cord stimulation as an
adjunct therapy for chronic refractory angina pectoris. Int J
Cardiol. 227:535–542. 2017. View Article : Google Scholar
|
|
46
|
Palasubramaniam J, Wang X and Peter K:
Myocardial infarction-from atherosclerosis to thrombosis.
Arterioscler Thromb Vasc Biol. 39:e176–e185. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Libby P: Inflammation in atherosclerosis.
Nature. 420:868–874. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Bradley C and Berry C: Definition and
epidemiology of coronary microvascular disease. J Nucl Cardiol.
29:1763–1775. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Marinescu MA, Löffler AI, Ouellette M,
Smith L, Kramer CM and Bourque JM: Coronary microvascular
dysfunction, microvascular angina, and treatment strategies. JACC
Cardiovasc Imaging. 8:210–220. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Gutiérrez E, Flammer AJ, Lerman LO,
Elízaga J, Lerman A and Fernández-Avilés F: Endothelial dysfunction
over the course of coronary artery disease. Eur Heart J.
34:3175–3181. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Bentzon JF, Otsuka F, Virmani R and Falk
E: Mechanisms of plaque formation and rupture. Circ Res.
114:1852–1866. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Villa AD, Sammut E, Nair A, Rajani R,
Bonamini R and Chiribiri A: Coronary artery anomalies overview: The
normal and the abnormal. World J Radiol. 8:537–555. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Chen M, Wu X and Xu C: The 'hands'
teaching method in coronary artery anatomy. Asian J Surg.
47:3183–3184. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Chilian WM and Marcus ML: Phasic coronary
blood flow velocity in intramural and epicardial coronary arteries.
Circ Res. 50:775–781. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
De Bruyne B, Hersbach F, Pijls NH,
Bartunek J, Bech JW, Heyndrickx GR, Gould KL and Wijns W: Abnormal
epicardial coronary resistance in patients with diffuse
atherosclerosis but 'normal' coronary angiography. Circulation.
104:2401–2406. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Camici PG and Rimoldi OE: The clinical
value of myocardial blood flow measurement. J Nucl Med.
50:1076–1087. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Duncker DJ, Koller A, Merkus D and Canty
JM Jr: Regulation of coronary blood flow in health and ischemic
heart disease. Prog Cardiovasc Dis. 57:409–422. 2015. View Article : Google Scholar
|
|
58
|
Dedkov EI, Christensen LP, Weiss RM and
Tomanek RJ: Reduction of heart rate by chronic beta1-adrenoceptor
blockade promotes growth of arterioles and preserves coronary
perfusion reserve in postinfarcted heart. Am J Physiol Heart Circ
Physiol. 288:H2684–H2693. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Pruthi S, Siddiqui E and Smilowitz NR:
Beyond coronary artery disease: Assessing the microcirculation.
Interv Cardiol Clin. 12:119–129. 2023.
|
|
60
|
Palade GE: Blood capillaries of the heart
and other organs. Circulation. 24:368–388. 1961. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Wolff CB: Normal cardiac output, oxygen
delivery and oxygen extraction. Adv Exp Med Biol. 599:169–182.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Gandoy-Fieiras N, Gonzalez-Juanatey JR and
Eiras S: Myocardium metabolism in physiological and
pathophysiological states: Implications of epicardial adipose
tissue and potential therapeutic targets. Int J Mol Sci.
21:26412020. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Hollenberg M and Tager IB: Oxygen uptake
efficiency slope: An index of exercise performance and
cardiopulmonary reserve requiring only submaximal exercise. J Am
Coll Cardiol. 36:194–201. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Downey JM: Myocardial contractile force as
a function of coronary blood flow. Am J Physiol. 230:1–6. 1976.
View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Heusch G: Heart rate in the
pathophysiology of coronary blood flow and myocardial ischaemia:
Benefit from selective bradycardic agents. Br J Pharmacol.
153:1589–1601. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Seligman H, Nijjer SS, van de Hoef TP, de
Waard GA, Mejía-Rentería H, Echavarria-Pinto M, Shun-Shin MJ,
Howard JP, Cook CM, Warisawa T, et al: Phasic flow patterns of
right versus left coronary arteries in patients undergoing clinical
physiological assessment. EuroIntervention. 17:1260–1270. 2022.
View Article : Google Scholar
|
|
67
|
Comunale G, Peruzzo P, Castaldi B,
Razzolini R, Di Salvo G, Padalino MA and Susin FM: Understanding
and recognition of the right ventricular function and dysfunction
via a numerical study. Sci Rep. 11:37092021. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Nikorowitsch J, Bei der Kellen R, Haack A,
Magnussen C, Prochaska J, Wild PS, Dörr M, Twerenbold R, Schnabel
RB, Kirchhof P, et al: Correlation of systolic and diastolic blood
pressure with echocardiographic phenotypes of cardiac structure and
function from three German population-based studies. Sci Rep.
13:145252023. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Yang HJ, Dey D, Sykes J, Klein M, Butler
J, Kovacs MS, Sobczyk O, Sharif B, Bi X, Kali A, et al: Arterial
CO2 as a potent coronary vasodilator: A preclinical
PET/MR validation study with implications for cardiac stress
testing. J Nucl Med. 58:953–960. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Shryock JC, Snowdy S, Baraldi PG, Cacciari
B, Spalluto G, Monopoli A, Ongini E, Baker SP and Belardinelli L:
A2A-adenosine receptor reserve for coronary vasodilation.
Circulation. 98:711–718. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Mori K, Nakaya Y, Sakamoto S, Hayabuchi Y,
Matsuoka S and Kuroda Y: Lactate-induced vascular relaxation in
porcine coronary arteries is mediated by Ca2+-activated K+
channels. J Mol Cell Cardiol. 30:349–356. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Tarnow J, Brückner JB, Eberlein HJ,
Gethmann JW, Hess W, Patschke D and Wilde J: Blood pH and PaCO2 as
chemical factors in myocardial blood flow control. Basic Res
Cardiol. 70:685–696. 1975. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Ishizaka H and Kuo L: Acidosis-induced
coronary arteriolar dilation is mediated by ATP-sensitive potassium
channels in vascular smooth muscle. Circ Res. 78:50–57. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Knot HJ, Zimmermann PA and Nelson MT:
Extracellular K(+)-induced hyperpolarizations and dilatations of
rat coronary and cerebral arteries involve inward rectifier K(+)
channels. J Physiol. 492:419–430. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Dora KA, Borysova L, Ye X, Powell C,
Beleznai TZ, Stanley CP, Bruno VD, Starborg T, Johnson E, Pielach
A, et al: Human coronary microvascular contractile dysfunction
associates with viable synthetic smooth muscle cells. Cardiovasc
Res. 118:1978–1992. 2022. View Article : Google Scholar :
|
|
76
|
Zhuge Y, Zhang J, Qian F, Wen Z, Niu C, Xu
K, Ji H, Rong X, Chu M and Jia C: Role of smooth muscle cells in
cardiovascular disease. Int J Biol Sci. 16:2741–2751. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Young MA, Knight DR and Vatner SF:
Autonomic control of large coronary arteries and resistance
vessels. Prog Cardiovasc Dis. 30:211–234. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Seddon M, Melikian N, Dworakowski R,
Shabeeh H, Jiang B, Byrne J, Casadei B, Chowienczyk P and Shah AM:
Effects of neuronal nitric oxide synthase on human coronary artery
diameter and blood flow in vivo. Circulation. 119:2656–2662. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Schrör K: Possible role of prostaglandins
in the regulation of coronary blood flow. Basic Res Cardiol.
76:239–249. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Dharmashankar K and Widlansky ME: Vascular
endothelial function and hypertension: Insights and directions.
Curr Hypertens Rep. 12:448–455. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Lu Y, Cui X, Zhang L, Wang X, Xu Y, Qin Z,
Liu G, Wang Q, Tian K, Lim KS, et al: The functional role of
lipoproteins in atherosclerosis: Novel directions for diagnosis and
targeting therapy. Aging Dis. 13:491–520. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Kobayashi Y, Sakai C, Ishida T, Nagata M,
Nakano Y and Ishida M: Mitochondrial DNA is a key driver in
cigarette smoke extract-induced IL-6 expression. Hypertens Res.
47:88–101. 2024. View Article : Google Scholar
|
|
83
|
Mundi S, Massaro M, Scoditti E, Carluccio
MA, van Hinsbergh VWM, Iruela-Arispe ML and De Caterina R:
Endothelial permeability, LDL deposition, and cardiovascular risk
factors-a review. Cardiovasc Res. 114:35–52. 2018. View Article : Google Scholar
|
|
84
|
Falk E: Pathogenesis of atherosclerosis. J
Am Coll Cardiol. 47(8 Suppl): C7–C12. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Aviram M: Macrophage foam cell formation
during early atherogenesis is determined by the balance between
pro-oxidants and anti-oxidants in arterial cells and blood
lipoproteins. Antioxid Redox Signal. 1:585–594. 1999. View Article : Google Scholar
|
|
86
|
Willemsen L and de Winther MP: Macrophage
subsets in atherosclerosis as defined by single-cell technologies.
J Pathol. 250:705–714. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Newby AC and Zaltsman AB: Fibrous cap
formation or destruction-the critical importance of vascular smooth
muscle cell proliferation, migration and matrix formation.
Cardiovasc Res. 41:345–360. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Allahverdian S, Chehroudi AC, McManus BM,
Abraham T and Francis GA: Contribution of intimal smooth muscle
cells to cholesterol accumulation and macrophage-like cells in
human atherosclerosis. Circulation. 129:1551–1559. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Rong JX, Shapiro M, Trogan E and Fisher
EA: Transdifferentiation of mouse aortic smooth muscle cells to a
macrophage-like state after cholesterol loading. Proc Natl Acad Sci
USA. 100:13531–13536. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Ajoolabady A, Pratico D, Lin L, Mantzoros
CS, Bahijri S, Tuomilehto J and Ren J: Inflammation in
atherosclerosis: Pathophysiology and mechanisms. Cell Death Dis.
15:8172024. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Song B, Bie Y, Feng H, Xie B, Liu M and
Zhao F: Inflammatory factors driving atherosclerotic plaque
progression new insights. J Transl Int Med. 10:36–47. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Francisco J and Del Re DP: Inflammation in
myocardial ischemia/reperfusion injury: Underlying mechanisms and
therapeutic potential. Antioxidants (Basel). 12:19442023.
View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Bennett MR, Sinha S and Owens GK: Vascular
smooth muscle cells in atherosclerosis. Circ Res. 118:692–702.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Otsuka F, Kramer MCA, Woudstra P, Yahagi
K, Ladich E, Finn AV, de Winter RJ, Kolodgie FD, Wight TN, Davis
HR, et al: Natural progression of atherosclerosis from pathologic
intimal thickening to late fibroatheroma in human coronary
arteries: A pathology study. Atherosclerosis. 241:772–782. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Badimon L and Vilahur G: Thrombosis
formation on atherosclerotic lesions and plaque rupture. J Intern
Med. 276:618–632. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Kumar A, Kar S and Fay WP: Thrombosis,
physical activity, and acute coronary syndromes. J Appl Physiol
(1985). 111:599–605. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Ha EJ, Kim Y, Cheung JY and Shim SS:
Coronary artery disease in asymptomatic young adults: Its
prevalence according to coronary artery disease risk stratification
and the CT characteristics. Korean J Radiol. 11:425–432. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Dzaye O, Razavi AC, Blaha MJ and Mortensen
MB: Evaluation of coronary stenosis versus plaque burden for
atherosclerotic cardiovascular disease risk assessment and
management. Curr Opin Cardiol. 36:769–775. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Kragel AH, Reddy SG, Wittes JT and Roberts
WC: Morphometric analysis of the composition of atherosclerotic
plaques in the four major epicardial coronary arteries in acute
myocardial infarction and in sudden coronary death. Circulation.
80:1747–1756. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Servoss SJ, Januzzi JL and Muller JE:
Triggers of acute coronary syndromes. Prog Cardiovasc Dis.
44:369–380. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Burke AP, Kolodgie FD, Farb A, Weber DK,
Malcom GT, Smialek J and Virmani R: Healed plaque ruptures and
sudden coronary death: Evidence that subclinical rupture has a role
in plaque progression. Circulation. 103:934–940. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Amabile N and Veugeois A: Ruptured and
healed atherosclerotic plaques: Breaking bad? EuroIntervention.
15:e742–e744. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Rittersma SZH, van der Wal AC, Koch KT,
Piek JJ, Henriques JP, Mulder KJ, Ploegmakers JP, Meesterman M and
de Winter RJ: Plaque instability frequently occurs days or weeks
before occlusive coronary thrombosis: A pathological thrombectomy
study in primary percutaneous coronary intervention. Circulation.
111:1160–1165. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Fernández-Ortiz A, Badimon JJ, Falk E,
Fuster V, Meyer B, Mailhac A, Weng D, Shah PK and Badimon L:
Characterization of the relative thrombogenicity of atherosclerotic
plaque components: Implications for consequences of plaque rupture.
J Am Coll Cardiol. 23:1562–1569. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Silvain J, Collet JP, Nagaswami C, Beygui
F, Edmondson KE, Bellemain-Appaix A, Cayla G, Pena A, Brugier D,
Barthelemy O, et al: Composition of coronary thrombus in acute
myocardial infarction. J Am Coll Cardiol. 57:1359–1367. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Mohammed AQ, Abdu FA, Liu L, Yin G, Mareai
RM, Mohammed AA, Xu Y and Che W: Coronary microvascular dysfunction
and myocardial infarction with non-obstructive coronary arteries:
Where do we stand? Eur J Intern Med. 117:8–20. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Herrmann J, Kaski JC and Lerman A:
Coronary microvascular dysfunction in the clinical setting: From
mystery to reality. Eur Heart J. 33:2771–2782b. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Sinha A, Rahman H and Perera D: Coronary
microvascular disease: Current concepts of pathophysiology,
diagnosis and management. Cardiovasc Endocrinol Metab. 10:22–30.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Rezaeian P, Shufelt CL, Wei J, Pacheco C,
Cook-Wiens G, Berman D, Tamarappoo B, Thomson LE, Nelson MD,
Anderson RD, et al: Arterial stiffness assessment in coronary
microvascular dysfunction and heart failure with preserved ejection
fraction: An initial report from the WISE-CVD continuation study.
Am Heart J Plus. 41:1003902024.PubMed/NCBI
|
|
110
|
Singh A, Ashraf S, Irfan H, Venjhraj F,
Verma A, Shaukat A, Tariq MD and Hamza HM: Heart failure and
microvascular dysfunction: An in-depth review of mechanisms,
diagnostic strategies, and innovative therapies. Ann Med Surg
(Lond). 87:616–626. 2024. View Article : Google Scholar
|
|
111
|
Li M, Qian M, Kyler K and Xu J:
Endothelial-vascular smooth muscle cells interactions in
atherosclerosis. Front Cardiovasc Med. 5:1512018. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Medina-Leyte DJ, Zepeda-García O,
Domínguez-Pérez M, González-Garrido A, Villarreal-Molina T and
Jacobo-Albavera L: Endothelial dysfunction, inflammation and
coronary artery disease: potential biomarkers and promising
therapeutical approaches. Int J Mol Sci. 22:38502021. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Fleissner F and Thum T: Critical role of
the nitric oxide/reactive oxygen species balance in endothelial
progenitor dysfunction. Antioxid Redox Signal. 15:933–948. 2011.
View Article : Google Scholar :
|
|
114
|
Goodwill AG, Dick GM, Kiel AM and Tune JD:
Regulation of coronary blood flow. Compr Physiol. 7:321–382. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Maddox TM, Stanislawski MA, Grunwald GK,
Bradley SM, Ho PM, Tsai TT, Patel MR, Sandhu A, Valle J, Magid DJ,
et al: Nonobstructive coronary artery disease and risk of
myocardial infarction. JAMA. 312:1754–1763. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Heusch G: Myocardial ischemia: Lack of
coronary blood flow or myocardial oxygen supply/demand imbalance?
Circ Res. 119:194–196. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Pasupathy S, Tavella R and Beltrame JF:
Myocardial infarction with nonobstructive coronary arteries
(MINOCA): The past, present, and future management. Circulation.
135:1490–1493. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Ford TJ, Rocchiccioli P, Good R,
McEntegart M, Eteiba H, Watkins S, Shaukat A, Lindsay M, Robertson
K, Hood S, et al: Systemic microvascular dysfunction in
microvascular and vasospastic angina. Eur Heart J. 39:4086–4097.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Mohri M, Koyanagi M, Egashira K, Tagawa H,
Ichiki T, Shimokawa H and Takeshita A: Angina pectoris caused by
coronary microvascular spasm. Lancet. 351:1165–1169. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Mehta PK, Thobani A and Vaccarino V:
Coronary artery spasm, coronary reactivity, and their psychological
context. Psychosom Med. 81:233–236. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Hung MJ, Hu P and Hung MY: Coronary artery
spasm: Review and update. Int J Med Sci. 11:1161–1171. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Igarashi Y, Yamazoe M and Shibata A:
Effect of direct intracoronary administration of methylergonovine
in patients with and without variant angina. Am Heart J.
121:1094–1100. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Frantz RP, Lerman A, Edwards BS, Olson LJ,
Higano ST, Schwartz RS, Daly RC, McGregor CG and Rodeheffer RJ:
Methylergonovine-induced diffuse coronary spasm in a patient with
exercise-induced coronary spasm after heart transplantation. J
Heart Lung Transplant. 13:834–839. 1994.PubMed/NCBI
|
|
124
|
Doenst T, Thiele H, Haasenritter J,
Wahlers T, Massberg S and Haverich A: The treatment of coronary
artery disease. Dtsch Arztebl Int. 119:716–723. 2022.PubMed/NCBI
|
|
125
|
Hennekens CH: Aspirin in the treatment and
prevention of cardiovascular disease. Annu Rev Public Health.
18:37–49. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Sabatine MS, Wiviott SD, Im K, Murphy SA
and Giugliano RP: Efficacy and safety of further lowering of
low-density lipoprotein cholesterol in patients starting with very
low levels: A meta-analysis. JAMA Cardiol. 3:823–828. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Manikandan A, Moharil P, Sathishkumar M,
Muñoz-Garay C and Sivakumar A: Therapeutic investigations of novel
indoxyl-based indolines: A drug target validation and
structure-activity relationship of angiotensin-converting enzyme
inhibitors with cardiovascular regulation and thrombolytic
potential. Eur J Med Chem. 141:417–426. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Godoy LC, Farkouh ME, Austin PC, Shah BR,
Qiu F, Jackevicius CA, Wijeysundera HC, Krumholz HM and Ko DT:
Association of beta-blocker therapy with cardiovascular outcomes in
patients with stable ischemic heart disease. J Am Coll Cardiol.
81:2299–2311. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Yan Y, An W, Mei S, Zhu Q, Li C, Yang L,
Zhao Z and Huo J: Real-world research on beta-blocker usage trends
in China and safety exploration based on the FDA adverse event
reporting system (FAERS). BMC Pharmacol Toxicol. 25:862024.
View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Elliott WJ and Ram CVS: Calcium channel
blockers. J Clin Hypertens (Greenwich). 13:687–689. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Kalinowski L, Dobrucki LW,
Szczepanska-Konkel M, Jankowski M, Martyniec L, Angielski S and
Malinski T: Third-generation beta-blockers stimulate nitric oxide
release from endothelial cells through ATP efflux: A novel
mechanism for antihypertensive action. Circulation. 107:2747–2752.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Lawton JS, Tamis-Holland JE, Bangalore S,
Bates ER, Beckie TM, Bischoff JM, Bittl JA, Cohen MG, DiMaio JM,
Don CW, et al: 2021 ACC/AHA/SCAI guideline for coronary artery
revascularization: Executive summary: A report of the American
college of cardiology/american heart association joint committee on
clinical practice guidelines. Circulation. 145:e4–e17. 2022.
|
|
133
|
Head SJ, Kieser TM, Falk V, Huysmans HA
and Kappetein AP: Coronary artery bypass grafting: Part 1-the
evolution over the first 50 years. Eur Heart J. 34:2862–2872. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
134
|
Costa MACD, Betero AL, Okamoto J,
Schafranski M, Reis ESD and Gomes RZ: Coronary endarterectomy: A
case control study and evaluation of early patency rate of
endarterectomized arteries. Braz J Cardiovasc Surg. 35:9–15.
2020.PubMed/NCBI
|
|
135
|
González-Montero J, Brito R, Gajardo AI
and Rodrigo R: Myocardial reperfusion injury and oxidative stress:
Therapeutic opportunities. World J Cardiol. 10:74–86. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Hausenloy DJ and Yellon DM: Myocardial
ischemia-reperfusion injury: A neglected therapeutic target. J Clin
Invest. 123:92–100. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
137
|
McBride W, Lange RA and Hillis LD:
Restenosis after successful coronary angioplasty. Pathophysiology
and prevention. N Engl J Med. 318:1734–1737. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
138
|
Smart NA, Dieberg G and King N: Long-term
outcomes of on-versus off-pump coronary artery bypass grafting. J
Am Coll Cardiol. 71:983–991. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
139
|
Camici PG and Crea F: Coronary
microvascular dysfunction. N Engl J Med. 356:830–840. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
140
|
Roffi M, Meier B and Gallino A: Fifty
years of percutaneous transluminal angioplasty. Eur Heart J.
45:1779–1780. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
141
|
Ruel M and Chikwe J: Coronary artery
bypass grafting: Past and future. Circulation. 150:1067–1069. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
142
|
Rocco E, Grimaldi MC, Maino A, Cappannoli
L, Pedicino D, Liuzzo G and Biasucci LM: Advances and challenges in
biomarkers use for coronary microvascular dysfunction: From bench
to clinical practice. J Clin Med. 11:20552022. View Article : Google Scholar : PubMed/NCBI
|
|
143
|
Soleymani M, Masoudkabir F, Shabani M,
Vasheghani-Farahani A, Behnoush AH and Khalaji A: Updates on
pharmacologic management of microvascular angina. Cardiovasc Ther.
2022:60802582022. View Article : Google Scholar : PubMed/NCBI
|
|
144
|
Yang L, Zhao W, Kan Y, Ren C and Ji X:
From mechanisms to medicine: Neurovascular coupling in the
diagnosis and treatment of cerebrovascular disorders: A narrative
review. Cells. 14:162024. View Article : Google Scholar
|
|
145
|
Bairey Merz CN, Pepine CJ, Shimokawa H and
Berry C: Treatment of coronary microvascular dysfunction.
Cardiovasc Res. 116:856–870. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
146
|
Fatima M, Bazarbaev A, Rana A, Khurshid R,
Effiom V, Bajwa NK, Nasir A, Candelario K, Tabraiz SA, Colon S, et
al: Neuroprotective strategies in coronary artery disease
interventions. J Cardiovasc Dev Dis. 12:1432025.PubMed/NCBI
|
|
147
|
Manolis AA, Manolis TA, Apostolopoulos EJ,
Apostolaki NE, Melita H and Manolis AS: The role of the autonomic
nervous system in cardiac arrhythmias: The neuro-cardiac axis, more
foe than friend? Trends Cardiovasc Med. 31:290–302. 2021.
View Article : Google Scholar
|
|
148
|
Armour JA: Functional anatomy of
intrathoracic neurons innervating the atria and ventricles. Heart
Rhythm. 7:994–996. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
149
|
Brodde OE, Bruck H, Leineweber K and
Seyfarth T: Presence, distribution and physiological function of
adrenergic and muscarinic receptor subtypes in the human heart.
Basic Res Cardiol. 96:528–538. 2001. View Article : Google Scholar
|
|
150
|
Kawashima T: The autonomic nervous system
of the human heart with special reference to its origin, course,
and peripheral distribution. Anat Embryol (Berl). 209:425–438.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
151
|
Burnstock G: Autonomic neurotransmission:
60 Years since sir henry dale. Annu Rev Pharmacol Toxicol. 49:1–30.
2009. View Article : Google Scholar
|
|
152
|
Nikolaidis LA, Trumble D, Hentosz T,
Doverspike A, Huerbin R, Mathier MA, Shen YT and Shannon RP:
Catecholamines restore myocardial contractility in dilated
cardiomyopathy at the expense of increased coronary blood flow and
myocardial oxygen consumption (MvO2 cost of catecholamines in heart
failure). Eur J Heart Fail. 6:409–419. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
153
|
Rajendran PS, Challis RC, Fowlkes CC,
Hanna P, Tompkins JD, Jordan MC, Hiyari S, Gabris-Weber BA,
Greenbaum A, Chan KY, et al: Identification of peripheral neural
circuits that regulate heart rate using optogenetic and viral
vector strategies. Nat Commun. 10:19442019. View Article : Google Scholar : PubMed/NCBI
|
|
154
|
Machhada A, Hosford PS, Dyson A, Ackland
GL, Mastitskaya S and Gourine AV: Optogenetic stimulation of vagal
efferent activity preserves left ventricular function in
experimental heart failure. JACC Basic Transl Sci. 5:799–810. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
155
|
Finlay M, Harmer SC and Tinker A: The
control of cardiac ventricular excitability by autonomic pathways.
Pharmacol Ther. 174:97–111. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
156
|
Kawano H, Okada R and Yano K: Histological
study on the distribution of autonomic nerves in the human heart.
Heart Vessels. 18:32–39. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
157
|
Liu X, Yu Y, Zhang H, Zhang M and Liu Y:
The role of muscarinic acetylcholine receptor M3 in
cardiovascular diseases. Int J Mol Sci. 25:75602024. View Article : Google Scholar
|
|
158
|
Giannino G, Braia V, Griffith Brookles C,
Giacobbe F, D'Ascenzo F, Angelini F, Saglietto A, De Ferrari GM and
Dusi V: The intrinsic cardiac nervous system: From pathophysiology
to therapeutic implications. Biology (Basel). 13:1052024.PubMed/NCBI
|
|
159
|
Armour JA, Murphy DA, Yuan BX, Macdonald S
and Hopkins DA: Gross and microscopic anatomy of the human
intrinsic cardiac nervous system. Anat Rec. 247:289–298. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
160
|
Wake E and Brack K: Characterization of
the intrinsic cardiac nervous system. Auton Neurosci. 199:3–16.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
161
|
Fedele L and Brand T: The intrinsic
cardiac nervous system and its role in cardiac pacemaking and
conduction. J Cardiovasc Dev Dis. 7:542020.PubMed/NCBI
|
|
162
|
Rysevaite K, Saburkina I, Pauziene N,
Noujaim SF, Jalife J and Pauza DH: Morphologic pattern of the
intrinsic ganglionated nerve plexus in mouse heart. Heart Rhythm.
8:448–454. 2011. View Article : Google Scholar
|
|
163
|
Kimura K, Ieda M and Fukuda K:
Development, maturation, and transdifferentiation of cardiac
sympathetic nerves. Circ Res. 110:325–336. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
164
|
Rajendran PS, Nakamura K, Ajijola OA,
Vaseghi M, Armour JA, Ardell JL and Shivkumar K: Myocardial
infarction induces structural and functional remodelling of the
intrinsic cardiac nervous system. J Physiol. 594:321–341. 2016.
View Article : Google Scholar :
|
|
165
|
Gardner RT, Ripplinger CM, Myles RC and
Habecker BA: Molecular mechanisms of sympathetic remodeling and
arrhythmias. Circ Arrhythm Electrophysiol. 9:e0013592016.
View Article : Google Scholar : PubMed/NCBI
|
|
166
|
Hopkins DA, Macdonald SE, Murphy DA and
Armour JA: Pathology of intrinsic cardiac neurons from ischemic
human hearts. Anat Rec. 259:424–436. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
167
|
Hardwick JC, Ryan SE, Beaumont E, Ardell
JL and Southerland EM: Dynamic remodeling of the guinea pig
intrinsic cardiac plexus induced by chronic myocardial infarction.
Auton Neurosci. 181:4–12. 2014. View Article : Google Scholar :
|
|
168
|
Vaseghi M, Salavatian S, Rajendran PS,
Yagishita D, Woodward WR, Hamon D, Yamakawa K, Irie T, Habecker BA
and Shivkumar K: Parasympathetic dysfunction and antiarrhythmic
effect of vagal nerve stimulation following myocardial infarction.
JCI Insight. 2:e867152017. View Article : Google Scholar : PubMed/NCBI
|
|
169
|
Yperzeele L, van Hooff RJ, Nagels G, De
Smedt A, De Keyser J and Brouns R: Heart rate variability and
baroreceptor sensitivity in acute stroke: A systematic review. Int
J Stroke. 10:796–800. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
170
|
Grilletti JVF, Scapini KB, Bernardes N,
Spadari J, Bigongiari A, Mazuchi FAES, Caperuto EC, Sanches IC,
Rodrigues B and De Angelis K: Impaired baroreflex sensitivity and
increased systolic blood pressure variability in chronic
post-ischemic stroke. Clinics (Sao Paulo). 73:e2532018. View Article : Google Scholar : PubMed/NCBI
|
|
171
|
Chen Z, Venkat P, Seyfried D, Chopp M, Yan
T and Chen J: Brain-heart interaction: Cardiac complications after
stroke. Circ Res. 121:451–468. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
172
|
Tang S, Xiong L, Fan Y, Mok VCT, Wong KS
and Leung TW: Stroke outcome prediction by blood pressure
variability, heart rate variability, and baroreflex sensitivity.
Stroke. 51:1317–1320. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
173
|
Aftyka J, Staszewski J, Dębiec A,
Pogoda-Wesołowska A and Żebrowski J: Heart rate variability as a
predictor of stroke course, functional outcome, and medical
complications: A systematic review. Front Physiol. 14:11151642023.
View Article : Google Scholar : PubMed/NCBI
|
|
174
|
Giunta S, Xia S, Pelliccioni G and
Olivieri F: Autonomic nervous system imbalance during aging
contributes to impair endogenous anti-inflammaging strategies.
Geroscience. 46:113–127. 2024. View Article : Google Scholar :
|
|
175
|
Bruno RM, Ghiadoni L, Seravalle G,
Dell'oro R, Taddei S and Grassi G: Sympathetic regulation of
vascular function in health and disease. Front Physiol. 3:2842012.
View Article : Google Scholar : PubMed/NCBI
|
|
176
|
Amiya E, Watanabe M and Komuro I: The
relationship between vascular function and the autonomic nervous
system. Ann Vasc Dis. 7:109–119. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
177
|
He Z: The control mechanisms of heart rate
dynamics in a new heart rate nonlinear time series model. Sci Rep.
10:48142020. View Article : Google Scholar : PubMed/NCBI
|
|
178
|
Valensi P: Autonomic nervous system
activity changes in patients with hypertension and overweight: Role
and therapeutic implications. Cardiovasc Diabetol. 20:1702021.
View Article : Google Scholar : PubMed/NCBI
|
|
179
|
Monahan KD, Feehan RP, Sinoway LI and Gao
Z: Contribution of sympathetic activation to coronary
vasodilatation during the cold pressor test in healthy men: Effect
of ageing. J Physiol. 591:2937–2947. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
180
|
Hoffman JIE and Buckberg GD: The
myocardial oxygen supply: Demand index revisited. J Am Heart Assoc.
3:e0002852014. View Article : Google Scholar
|
|
181
|
Hartupee J and Mann DL: Neurohormonal
activation in heart failure with reduced ejection fraction. Nat Rev
Cardiol. 14:30–38. 2017. View Article : Google Scholar :
|
|
182
|
Remme WJ: The sympathetic nervous system
and ischaemic heart disease. Eur Heart J. 19(Suppl F): F62–F71.
1998.PubMed/NCBI
|
|
183
|
Szczepanska-Sadowska E: Neuromodulation of
cardiac ischemic pain: Role of the autonomic nervous system and
vasopressin. J Integr Neurosci. 23:492024. View Article : Google Scholar : PubMed/NCBI
|
|
184
|
Wu L, Tai Y, Hu S, Zhang M, Wang R, Zhou
W, Tao J, Han Y, Wang Q and Wei W: Bidirectional role of
β2-adrenergic receptor in autoimmune diseases. Front Pharmacol.
9:13132018. View Article : Google Scholar
|
|
185
|
Grisanti LA, Perez DM and Porter JE:
Modulation of immune cell function by α(1)-adrenergic receptor
activation. Curr Top Membr. 67:113–138. 2011. View Article : Google Scholar
|
|
186
|
Perez DM: α1-Adrenergic
receptors: insights into potential therapeutic opportunities for
COVID-19, heart failure, and Alzheimer's disease. Int J Mol Sci.
24:41882023. View Article : Google Scholar
|
|
187
|
Kinugawa T, Kato M, Ogino K, Osaki S,
Tomikura Y, Igawa O, Hisatome I and Shigemasa C: Interleukin-6 and
tumor necrosis factor-alpha levels increase in response to maximal
exercise in patients with chronic heart failure. Int J Cardiol.
87:83–90. 2003. View Article : Google Scholar
|
|
188
|
Li M, Yao W, Li S and Xi J: Norepinephrine
induces the expression of interleukin-6 via
β-adrenoreceptor-NAD(P)H oxidase system-NF-κB dependent signal
pathway in U937 macrophages. Biochem Biophys Res Commun.
460:1029–1034. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
189
|
Al-Sharea A, Lee MKS, Whillas A, Michell
DL, Shihata WA, Nicholls AJ, Cooney OD, Kraakman MJ, Veiga CB,
Jefferis AM, et al: Chronic sympathetic driven hypertension
promotes atherosclerosis by enhancing hematopoiesis. Haematologica.
104:456–467. 2019. View Article : Google Scholar :
|
|
190
|
Stone PH, Libby P and Boden WE:
Fundamental pathobiology of coronary atherosclerosis and clinical
implications for chronic ischemic heart disease management-the
plaque hypothesis: A narrative review. JAMA Cardiol. 8:192–201.
2023. View Article : Google Scholar
|
|
191
|
Wang Y, Anesi J, Maier MC, Myers MA,
Oqueli E, Sobey CG, Drummond GR and Denton KM: Sympathetic nervous
system and atherosclerosis. Int J Mol Sci. 24:131322023. View Article : Google Scholar : PubMed/NCBI
|
|
192
|
Chen YC, Smith M, Ying YL, Makridakis M,
Noonan J, Kanellakis P, Rai A, Salim A, Murphy A, Bobik A, et al:
Quantitative proteomic landscape of unstable atherosclerosis
identifies molecular signatures and therapeutic targets for plaque
stabilization. Commun Biol. 6:2652023. View Article : Google Scholar : PubMed/NCBI
|
|
193
|
Apolloni S and D'Ambrosi N: Inflammation
in the CNS and PNS: From molecular basis to therapy. Int J Mol Sci.
24:94172023. View Article : Google Scholar : PubMed/NCBI
|
|
194
|
Zanos S: Closed-loop neuromodulation in
physiological and translational research. Cold Spring Harb Perspect
Med. 9:a0343142019. View Article : Google Scholar
|
|
195
|
Ali R and Schwalb JM: History and future
of spinal cord stimulation. Neurosurgery. 94:20–28. 2024.
|
|
196
|
Ferraro MC, Gibson W, Rice ASC, Vase L,
Coyle D and O'Connell NE: Spinal cord stimulation for chronic pain.
Lancet Neurol. 21:4052022. View Article : Google Scholar : PubMed/NCBI
|
|
197
|
Augustinsson LE, Linderoth B, Mannheimer C
and Eliasson T: Spinal cord stimulation in cardiovascular disease.
Neurosurg Clin N Am. 6:157–165. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
198
|
Theofilis P, Oikonomou E, Sagris M,
Papageorgiou N, Tsioufis K and Tousoulis D: Novel concepts in the
management of angina in coronary artery disease. Curr Pharm Des.
29:1825–1834. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
199
|
Greco S, Auriti A, Fiume D, Gazzeri G,
Gentilucci G, Antonini L and Santini M: Spinal cord stimulation for
the treatment of refractory angina pectoris: A two-year follow-up.
Pacing Clin Electrophysiol. 22:26–32. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
200
|
Jessurun GA, DeJongste MJ, Hautvast RW,
Tio RA, Brouwer J, van Lelieveld S and Crijns HJ: Clinical
follow-up after cessation of chronic electrical neuromodulation in
patients with severe coronary artery disease: A prospective
randomized controlled study on putative involvement of sympathetic
activity. Pacing Clin Electrophysiol. 22:1432–1439. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
201
|
Eddicks S, Maier-Hauff K, Schenk M, Müller
A, Baumann G and Theres H: Thoracic spinal cord stimulation
improves functional status and relieves symptoms in patients with
refractory angina pectoris: The first placebo-controlled randomised
study. Heart. 93:585–590. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
202
|
de Jongste MJ, Hautvast RW, Hillege HL and
Lie KI: Efficacy of spinal cord stimulation as adjuvant therapy for
intractable angina pectoris: A prospective, randomized clinical
study. Working group on neurocardiology. J Am Coll Cardiol.
23:1592–1597. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
203
|
Hautvast RW, Blanksma PK, DeJongste MJ,
Pruim J, van der Wall EE, Vaalburg W and Lie KI: Effect of spinal
cord stimulation on myocardial blood flow assessed by positron
emission tomography in patients with refractory angina pectoris. Am
J Cardiol. 77:462–467. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
204
|
Hautvast RW, DeJongste MJ, Staal MJ, van
Gilst WH and Lie KI: Spinal cord stimulation in chronic intractable
angina pectoris: A randomized, controlled efficacy study. Am Heart
J. 136:1114–1120. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
205
|
Vulink NC, Overgaauw DM, Jessurun GA,
Tenvaarwerk IA, Kropmans TJ, van der Schans CP, Middel B, Staal MJ
and Dejongste MJ: The effects of spinal cord stimulation on quality
of life in patients with therapeutically chronic refractory angina
pectoris. Neuromodulation. 2:33–40. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
206
|
McNab D, Khan SN, Sharples LD, Ryan JY,
Freeman C, Caine N, Tait S, Hardy I and Schofield PM: An open
label, single-centre, randomized trial of spinal cord stimulation
vs percutaneous myocardial laser revascularization in patients with
refractory angina pectoris: The SPiRiT trial. Eur Heart J.
27:1048–1053. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
207
|
Dyer MT, Goldsmith KA, Khan SN, Sharples
LD, Freeman C, Hardy I, Buxton MJ and Schofield PM: Clinical and
cost-effectiveness analysis of an open label, single-centre,
randomised trial of spinal cord stimulation (SCS) versus
percutaneous myocardial laser revascularisation (PMR) in patients
with refractory angina pectoris: The SPiRiT trial. Trials.
9:402008. View Article : Google Scholar : PubMed/NCBI
|
|
208
|
Bondesson S, Pettersson T, Erdling A,
Hallberg IR, Wackenfors A and Edvinsson L: Comparison of patients
undergoing enhanced external counterpulsation and spinal cord
stimulation for refractory angina pectoris. Coron Artery Dis.
19:627–634. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
209
|
Andréll P, Yu W, Gersbach P, Gillberg L,
Pehrsson K, Hardy I, Ståhle A, Andersen C and Mannheimer C:
Long-term effects of spinal cord stimulation on angina symptoms and
quality of life in patients with refractory angina pectoris-results
from the European angina registry link study (EARL). Heart.
96:1132–1136. 2010. View Article : Google Scholar
|
|
210
|
Lanza GA, Grimaldi R, Greco S, Ghio S,
Sarullo F, Zuin G, De Luca A, Allegri M, Di Pede F, Castagno D, et
al: Spinal cord stimulation for the treatment of refractory angina
pectoris: A multicenter randomized single-blind study (the SCS-ITA
trial). Pain. 152:45–52. 2011. View Article : Google Scholar
|
|
211
|
Saraste A, Ukkonen H, Varis A, Vasankari
T, Tunturi S, Taittonen M, Rautakorpi P, Luotolahti M, Airaksinen
KE and Knuuti J: Effect of spinal cord stimulation on myocardial
perfusion reserve in patients with refractory angina pectoris. Eur
Heart J Cardiovasc Imaging. 16:449–455. 2015. View Article : Google Scholar
|
|
212
|
Latif OA, Nedeljkovic SS and Stevenson LW:
Spinal cord stimulation for chronic intractable angina pectoris: A
unified theory on its mechanism. Clin Cardiol. 24:533–541. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
213
|
Southerland EM, Milhorn DM, Foreman RD,
Linderoth B, DeJongste MJ, Armour JA, Subramanian V, Singh M, Singh
K and Ardell JL: Preemptive, but not reactive, spinal cord
stimulation mitigates transient ischemia-induced myocardial
infarction via cardiac adrenergic neurons. Am J Physiol Heart Circ
Physio. 292:H311–H327. 2007. View Article : Google Scholar
|
|
214
|
Dale EA, Kipke J, Kubo Y, Sunshine MD,
Castro PA, Ardell JL and Mahajan A: Spinal cord neural network
interactions: Implications for sympathetic control of the porcine
heart. Am J Physiol Heart Circ Physiol. 318:H830–H839. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
215
|
Salavatian S, Kuwabara Y, Wong B, Fritz
JR, Howard-Quijano K, Foreman RD, Armour JA, Ardell JL and Mahajan
A: Spinal neuromodulation mitigates myocardial ischemia-induced
sympathoexcitation by suppressing the intermediolateral nucleus
hyperactivity and spinal neural synchrony. Front Neurosci.
17:11802942023. View Article : Google Scholar : PubMed/NCBI
|
|
216
|
Saddic LA, Howard-Quijano K, Kipke J, Kubo
Y, Dale EA, Hoover D, Shivkumar K, Eghbali M and Mahajan A:
Progression of myocardial ischemia leads to unique changes in
immediate-early gene expression in the spinal cord dorsal horn. Am
J Physiol Heart Circ Physiol. 315:H1592–H1601. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
217
|
Minisi AJ and Thames MD: Activation of
cardiac sympathetic afferents during coronary occlusion. Evidence
for reflex activation of sympathetic nervous system during
transmural myocardial ischemia in the dog. Circulation. 84:357–367.
1991. View Article : Google Scholar : PubMed/NCBI
|
|
218
|
Ajijola OA and Shivkumar K: Neural
remodeling and myocardial infarction: The stellate ganglion as a
double agent. J Am Coll Cardiol. 59:962–964. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
219
|
Ding X, Ardell JL, Hua F, McAuley RJ,
Sutherly K, Daniel JJ and Williams CA: Modulation of cardiac
ischemia-sensitive afferent neuron signaling by preemptive C2
spinal cord stimulation: Effect on substance P release from rat
spinal cord. Am J Physiol Regul Integr Comp Physiol. 294:R93–R101.
2008. View Article : Google Scholar
|
|
220
|
Law M, Sachdeva R, Darrow D and
Krassioukov A: Cardiovascular effects of spinal cord stimulation:
The highs, the lows, and the don't knows. Neuromodulation.
27:1164–1176. 2024. View Article : Google Scholar
|
|
221
|
Tse HF, Turner S, Sanders P, Okuyama Y,
Fujiu K, Cheung CW, Russo M, Green MDS, Yiu KH, Chen P, et al:
Thoracic spinal cord stimulation for heart failure as a restorative
treatment (SCS HEART study): First-in-man experience. Heart Rhythm.
12:588–595. 2015. View Article : Google Scholar
|
|
222
|
Wu M, Linderoth B and Foreman RD: Putative
mechanisms behind effects of spinal cord stimulation on vascular
diseases: A review of experimental studies. Auton Neurosci.
138:9–23. 2008. View Article : Google Scholar
|
|
223
|
Gouveia FV, Warsi NM, Suresh H, Matin R
and Ibrahim GM: Neurostimulation treatments for epilepsy: Deep
brain stimulation, responsive neurostimulation and vagus nerve
stimulation. Neurotherapeutics. 21:e003082024. View Article : Google Scholar : PubMed/NCBI
|
|
224
|
Austelle CW, O'Leary GH, Thompson S,
Gruber E, Kahn A, Manett AJ, Short B and Badran BW: A comprehensive
review of vagus nerve stimulation for depression. Neuromodulation.
25:309–315. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
225
|
Gidron Y, Kupper N, Kwaijtaal M, Winter J
and Denollet J: Vagus-brain communication in
atherosclerosis-related inflammation: A neuroimmunomodulation
perspective of CAD. Atherosclerosis. 195:e1–e9. 2007. View Article : Google Scholar
|
|
226
|
Giordano F, Zicca A, Barba C, Guerrini R
and Genitori L: Vagus nerve stimulation: Surgical technique of
implantation and revision and related morbidity. Epilepsia.
58(Suppl 1): S85–S90. 2017. View Article : Google Scholar
|
|
227
|
Winston GM, Guadix S, Lavieri MT,
Uribe-Cardenas R, Kocharian G, Williams N, Sholle E, Grinspan Z and
Hoffman CE: Closed-loop vagal nerve stimulation for intractable
epilepsy: A single-center experience. Seizure. 88:95–101. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
228
|
Skarpaas TL and Morrell MJ: Intracranial
stimulation therapy for epilepsy. Neurotherapeutics. 6:238–243.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
229
|
Sun FT and Morrell MJ: Closed-loop
neurostimulation: The clinical experience. Neurotherapeutics.
11:553–563. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
230
|
Ottaviani MM, Vallone F, Micera S and
Recchia FA: Closed-loop vagus nerve stimulation for the treatment
of cardiovascular diseases: State of the art and future directions.
Front Cardiovasc Med. 9:8669572022. View Article : Google Scholar : PubMed/NCBI
|
|
231
|
Vilaine JP, Berdeaux A and Giudicelli JF:
Effects of vagal stimulation on regional myocardial flows and
ischemic injury in dogs. Eur J Pharmacol. 66:243–247. 1980.
View Article : Google Scholar : PubMed/NCBI
|
|
232
|
Zuanetti G, De Ferrari GM, Priori SG and
Schwartz PJ: Protective effect of vagal stimulation on reperfusion
arrhythmias in cats. Circ Res. 61:429–435. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
233
|
Rosenshtraukh L, Danilo P Jr, Anyukhovsky
EP, Steinberg SF, Rybin V, Brittain-Valenti K, Molina-Viamonte V
and Rosen MR: Mechanisms for vagal modulation of ventricular
repolarization and of coronary occlusion-induced lethal arrhythmias
in cats. Circ Res. 75:722–732. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
234
|
Ando M, Katare RG, Kakinuma Y, Zhang D,
Yamasaki F, Muramoto K and Sato T: Efferent vagal nerve stimulation
protects heart against ischemia-induced arrhythmias by preserving
connexin43 protein. Circulation. 112:164–170. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
235
|
Uemura K, Li M, Tsutsumi T, Yamazaki T,
Kawada T, Kamiya A, Inagaki M, Sunagawa K and Sugimachi M: Efferent
vagal nerve stimulation induces tissue inhibitor of
metalloproteinase-1 in myocardial ischemia-reperfusion injury in
rabbit. Am J Physiol Heart Circ Physiol. 293:H2254–H2261. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
236
|
Del Rio CL, Dawson TA, Clymer BD, Paterson
DJ and Billman GE: Effects of acute vagal nerve stimulation on the
early passive electrical changes induced by myocardial ischaemia in
dogs: Heart rate-mediated attenuation. Exp Physiol. 93:931–944.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
237
|
Beaumont E, Southerland EM, Hardwick JC,
Wright GL, Ryan S, Li Y, KenKnight BH, Armour JA and Ardell JL:
Vagus nerve stimulation mitigates intrinsic cardiac neuronal and
adverse myocyte remodeling postmyocardial infarction. Am J Physiol
Heart Circ Physiol. 309:H1198–H1206. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
238
|
Zamotrinsky A, Afanasiev S, Karpov RS and
Cherniavsky A: Effects of electrostimulation of the vagus afferent
endings in patients with coronary artery disease. Coron Artery Dis.
8:551–557. 1997.PubMed/NCBI
|
|
239
|
Zamotrinsky AV, Kondratiev B and de Jong
JW: Vagal neurostimulation in patients with coronary artery
disease. Auton Neurosci. 88:109–116. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
240
|
Yu L, Huang B, Po SS, Tan T, Wang M, Zhou
L, Meng G, Yuan S, Zhou X, Li X, et al: Low-level tragus
stimulation for the treatment of ischemia and reperfusion injury in
patients with ST-segment elevation myocardial infarction: A
proof-of-concept study. JACC Cardiovasc Interv. 10:1511–1520. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
241
|
Bonaz B, Sinniger V and Pellissier S:
Anti-inflammatory properties of the vagus nerve: Potential
therapeutic implications of vagus nerve stimulation. J Physiol.
594:5781–5790. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
242
|
Li S, Qi D, Li JN, Deng XY and Wang DX:
Vagus nerve stimulation enhances the cholinergic anti-inflammatory
pathway to reduce lung injury in acute respiratory distress
syndrome via STAT3. Cell Death Discovery. 7:632021. View Article : Google Scholar : PubMed/NCBI
|
|
243
|
Hachuła M, Kosowski M, Basiak M and
Okopień B: Influence of dulaglutide on serum biomarkers of
atherosclerotic plaque instability: An interventional analysis of
cytokine profiles in diabetic subjects-a pilot study. Medicina
(Kaunas). 60:9082024. View Article : Google Scholar
|
|
244
|
Shinlapawittayatorn K, Chinda K, Palee S,
Surinkaew S, Thunsiri K, Weerateerangkul P, Chattipakorn S,
KenKnight BH and Chattipakorn N: Low-amplitude, left vagus nerve
stimulation significantly attenuates ventricular dysfunction and
infarct size through prevention of mitochondrial dysfunction during
acute ischemia-reperfusion injury. Heart Rhythm. 10:1700–1707.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
245
|
Lu Y, Chen K, Zhao W, Hua Y, Bao S, Zhang
J, Wu T, Ge G, Yu Y, Sun J and Zhang F: Magnetic vagus nerve
stimulation alleviates myocardial ischemia-reperfusion injury by
the inhibition of pyroptosis through the
M2AChR/OGDHL/ROS axis in rats. J Nanobiotechnology.
21:4212023. View Article : Google Scholar
|
|
246
|
Luo B, Wu Y, Liu SL, Li XY, Zhu HR, Zhang
L, Zheng F, Liu XY, Guo LY, Wang L, et al: Vagus nerve stimulation
optimized cardiomyocyte phenotype, sarcomere organization and
energy metabolism in infarcted heart through FoxO3A-VEGF signaling.
Cell Death Dis. 11:9712020. View Article : Google Scholar : PubMed/NCBI
|
|
247
|
Munhoz RP and Albuainain G: Deep brain
stimulation: New programming algorithms and teleprogramming. Expert
Rev Neurother. 23:467–478. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
248
|
Lee DJ, Lozano CS, Dallapiazza RF and
Lozano AM: Current and future directions of deep brain stimulation
for neurological and psychiatric disorders. J Neurosurg.
131:333–342. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
249
|
Basiago A and Binder DK: Effects of deep
brain stimulation on autonomic function. Brain Sci. 6:332016.
View Article : Google Scholar : PubMed/NCBI
|
|
250
|
Fontes MAP, Dos Santos Machado LR, Viana
ACR, Cruz MH, Nogueira ÍS, Oliveira MGL, Neves CB, Godoy ACV,
Henderson LA and Macefield VG: The insular cortex, autonomic
asymmetry and cardiovascular control: Looking at the right side of
stroke. Clin Auton Res. 34:549–560. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
251
|
Hyam JA, Kringelbach ML, Silburn PA, Aziz
TZ and Green AL: The autonomic effects of deep brain stimulation-a
therapeutic opportunity. Nat Rev Neurol. 8:391–400. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
252
|
Marins FR, Limborço-Filho M, Xavier CH,
Biancardi VC, Vaz GC, Stern JE, Oppenheimer SM and Fontes MA:
Functional topography of cardiovascular regulation along the
rostrocaudal axis of the rat posterior insular cortex. Clin Exp
Pharmacol Physiol. 43:484–493. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
253
|
Shivkumar K, Ajijola OA, Anand I, Armour
JA, Chen PS, Esler M, De Ferrari GM, Fishbein MC, Goldberger JJ,
Harper RM, et al: Clinical neurocardiology defining the value of
neuroscience-based cardiovascular therapeutics. J Physiol.
594:3911–3954. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
254
|
Sumi K, Katayama Y, Otaka T, Obuchi T,
Kano T, Kobayashi K, Oshima H, Fukaya C, Yamamoto T, Ogawa Y and
Iwasaki K: Effect of subthalamic nucleus deep brain stimulation on
the autonomic nervous system in Parkinson's disease patients
assessed by spectral analyses of R-R interval variability and blood
pressure variability. Stereotact Funct Neurosurg. 90:248–254. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
255
|
Zhang C, Xu J, Wu B, Ling Y, Guo Q, Wang
S, Liu L, Jiang N, Chen L and Liu J: Subthalamic nucleus deep brain
stimulation treats Parkinson's disease patients with cardiovascular
disease comorbidity: A retrospective study of a single center
experience. Brain Sci. 13:702022. View Article : Google Scholar
|
|
256
|
Rajkumar S, Venkatraman V, Yang LZ,
Parente B, Lee HJ and Lad SP: Short-term health care costs of
high-frequency spinal cord stimulation for the treatment of
postsurgical persistent spinal pain syndrome. Neuromodulation.
26:1450–1458. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
257
|
Kumar K, Caraway DL, Rizvi S and Bishop S:
Current challenges in spinal cord stimulation. Neuromodulation.
17(Suppl 1): S22–S35. 2014. View Article : Google Scholar
|
|
258
|
Yap JYY, Keatch C, Lambert E, Woods W,
Stoddart PR and Kameneva T: Critical review of transcutaneous vagus
nerve stimulation: Challenges for translation to clinical practice.
Front Neurosci. 14:2842020. View Article : Google Scholar : PubMed/NCBI
|
|
259
|
Austelle CW, Cox SS, Wills KE and Badran
BW: Vagus nerve stimulation (VNS): Recent advances and future
directions. Clin Auton Res. 34:529–547. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
260
|
Javan-Noughabi J, Rezapour A, Hajahmadi M
and Alipour V: Economic evaluation of single-photon
emission-computed tomography versus stress echocardiography in
stable chest pain patients. Sci Rep. 12:152232022. View Article : Google Scholar : PubMed/NCBI
|
|
261
|
Hijazi W, Vandenberk B, Rennert-May E,
Quinn A, Sumner G and Chew DS: Economic evaluation in cardiac
electrophysiology: Determining the value of emerging technologies.
Front Cardiovasc Med. 10:11424292023. View Article : Google Scholar : PubMed/NCBI
|
|
262
|
Tabaja H, Yuen J, Tai DBG, Campioli CC,
Chesdachai S, DeSimone DC, Hassan A, Klassen BT, Miller KJ, Lee KH
and Mahmood M: Deep brain stimulator device infection: The mayo
clinic rochester experience. Open Forum Infect Dis. 10:ofac6312022.
View Article : Google Scholar
|
|
263
|
Jung IH, Chang KW, Park SH, Chang WS, Jung
HH and Chang JW: Complications After deep brain stimulation: A
21-year experience in 426 patients. Front Aging Neurosci.
14:8197302022. View Article : Google Scholar : PubMed/NCBI
|
|
264
|
Olson MC, Shill H, Ponce F and Aslam S:
Deep brain stimulation in PD: Risk of complications, morbidity, and
hospitalizations: A systematic review. Front Aging Neurosci.
15:12581902023. View Article : Google Scholar : PubMed/NCBI
|
|
265
|
Lee JM, Lee D, Christiansen S, Hagedorn
JM, Chen Z and Deer T: Spinal cord stimulation in special
populations: Best practices from the american society of pain and
neuroscience to improve safety and efficacy. J Pain Res.
15:3263–3273. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
266
|
Ki YM, Park HJ, Yi SH, Sim WS and Lee JY:
Latent infection after spinal cord stimulation device implantation
for complex regional pain syndrome: A case report. Medicine
(Baltimore). 102:e337502023. View Article : Google Scholar : PubMed/NCBI
|
|
267
|
Vu PD, Pinkhasova D, Sarwary ZB, Rita
Markaryan A, Mousa B, Viswanath O, Robinson CL, Varrassi G, Orhurhu
V, Urits I and Hasoon J: Biologic complications associated with
cylindrical lead spinal cord stimulator implants: A narrative
review. Orthop Rev (Pavia). 16:1234432024. View Article : Google Scholar : PubMed/NCBI
|
|
268
|
Das S, Matias CM, Ramesh S, Velagapudi L,
Barbera JP, Katz S, Baldassari MP, Rasool M, Kremens D, Ratliff J,
et al: Capturing initial understanding and impressions of surgical
therapy for Parkinson's disease. Front Neurol. 12:6059592021.
View Article : Google Scholar : PubMed/NCBI
|
|
269
|
Salinas M, Yazdani U, Oblack A, McDaniels
B, Ahmed N, Haque B, Pouratian N and Chitnis S: Know DBS: Patient
perceptions and knowledge of deep brain stimulation in Parkinson's
disease. Ther Adv Neurol Disord. 17:175628642412330382024.
View Article : Google Scholar : PubMed/NCBI
|
|
270
|
Müller O and Rotter S: Neurotechnology:
Current developments and ethical issues. Front Syst Neurosci.
11:932017. View Article : Google Scholar
|
|
271
|
Faltus T, Freise J, Fluck C and Zillmann
H: Ethics and regulation of neuronal optogenetics in the European
Union. Pflugers Arch. 475:1505–1517. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
272
|
Jog MA, Anderson C, Kubicki A, Boucher M,
Leaver A, Hellemann G, Iacoboni M, Woods R and Narr K: Transcranial
direct current stimulation (tDCS) in depression induces structural
plasticity. Sci Rep. 13:28412023. View Article : Google Scholar : PubMed/NCBI
|
|
273
|
Lapa JDS, Duarte JFS, Campos ACP, Davidson
B, Nestor SM, Rabin JS, Giacobbe P, Lipsman N and Hamani C: Adverse
effects of deep brain stimulation for treatment-resistant
depression: A scoping review. Neurosurgery. 95:509–516. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
274
|
Siebner HR, Funke K, Aberra AS, Antal A,
Bestmann S, Chen R, Classen J, Davare M, Di Lazzaro V, Fox PT, et
al: Transcranial magnetic stimulation of the brain: What is
stimulated?-A consensus and critical position paper. Clin
Neurophysiol. 140:59–97. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
275
|
Iseger TA, van Bueren NER, Kenemans JL,
Gevirtz R and Arns M: A frontal-vagal network theory for major
depressive disorder: Implications for optimizing neuromodulation
techniques. Brain Stimul. 13:1–9. 2020. View Article : Google Scholar
|
|
276
|
Jiao Y, Cheng C, Jia M, Chu Z, Song X,
Zhang M, Xu H, Zeng X, Sun JB, Qin W and Yang XJ:
Neuro-cardiac-guided transcranial magnetic stimulation: Unveiling
the modulatory effects of low-frequency and high-frequency
stimulation on heart rate. Psychophysiology. 61:e146312024.
View Article : Google Scholar : PubMed/NCBI
|
|
277
|
Zou N, Zhou Q, Zhang Y, Xin C, Wang Y,
Claire-Marie R, Rong P, Gao G and Li S: Transcutaneous auricular
vagus nerve stimulation as a novel therapy connecting the central
and peripheral systems: A review. Int J Surg. 110:4993–5006. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
278
|
Afra P, Adamolekun B, Aydemir S and Watson
GDR: Evolution of the vagus nerve stimulation (VNS) therapy system
technology for drug-resistant epilepsy. Front Med Technol.
3:6965432021. View Article : Google Scholar
|
|
279
|
Habibagahi I, Omidbeigi M, Hadaya J, Lyu
H, Jang J, Ardell JL, Bari AA and Babakhani A: Vagus nerve
stimulation using a miniaturized wirelessly powered stimulator in
pigs. Sci Rep. 12:81842022. View Article : Google Scholar : PubMed/NCBI
|
|
280
|
Mirza KB, Golden CT, Nikolic K and
Toumazou C: Closed-loop implantable therapeutic neuromodulation
systems based on neurochemical monitoring. Front Neurosci.
13:8082019. View Article : Google Scholar : PubMed/NCBI
|
|
281
|
de Faria GM, Lopes EG, Tobaldini E,
Montano N, Cunha TS, Casali KR and de Amorim HA: Advances in
non-invasive neuromodulation: Designing closed-loop devices for
respiratory-controlled transcutaneous vagus nerve stimulation.
Healthcare (Basel). 12:312023. View Article : Google Scholar
|
|
282
|
Van Horn JD, Grafton ST and Miller MB:
Individual variability in brain activity: A nuisance or an
opportunity? Brain Imaging Behav. 2:327–334. 2008. View Article : Google Scholar
|
|
283
|
Li LM, Uehara K and Hanakawa T: The
contribution of interindividual factors to variability of response
in transcranial direct current stimulation studies. Front Cell
Neurosci. 9:1812015. View Article : Google Scholar : PubMed/NCBI
|
|
284
|
Seghier ML and Price CJ: Interpreting and
utilising intersubject variability in brain function. Trends Cogn
Sci. 22:517–530. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
285
|
Johnson MD, Lim HH, Netoff TI, Connolly
AT, Johnson N, Roy A, Holt A, Lim KO, Carey JR, Vitek JL and He B:
Neuromodulation for brain disorders: Challenges and opportunities.
IEEE Trans Biomed Eng. 60:610–624. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
286
|
Völzke H, Schmidt CO, Baumeister SE,
Ittermann T, Fung G, Krafczyk-Korth J, Hoffmann W, Schwab M, Meyer
zu Schwabedissen HE, Dörr M, et al: Personalized cardiovascular
medicine: Concepts and methodological considerations. Nat Rev
Cardiol. 10:308–316. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
287
|
Thompson N, Mastitskaya S and Holder D:
Avoiding off-target effects in electrical stimulation of the
cervical vagus nerve: Neuroanatomical tracing techniques to study
fascicular anatomy of the vagus nerve. J Neurosci Methods.
325:1083252019. View Article : Google Scholar : PubMed/NCBI
|
|
288
|
Fitchett A, Mastitskaya S and Aristovich
K: Selective neuromodulation of the vagus nerve. Front Neurosci.
15:6858722021. View Article : Google Scholar : PubMed/NCBI
|
|
289
|
Sclocco R, Garcia RG, Gabriel A, Kettner
NW, Napadow V and Barbieri R: Respiratory-gated auricular vagal
afferent nerve stimulation (RAVANS) effects on autonomic outflow in
hypertension. Annu Int Conf IEEE Eng Med Biol Soc. 2017:3130–3133.
2017.PubMed/NCBI
|
|
290
|
Garcia RG, Cohen JE, Stanford AD, Gabriel
A, Stowell J, Aizley H, Barbieri R, Gitlin D, Napadow V and
Goldstein JM: Respiratory-gated auricular vagal afferent nerve
stimulation (RAVANS) modulates brain response to stress in major
depression. J Psychiatr Res. 142:188–197. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
291
|
Cook DN, Thompson S, Stomberg-Firestein S,
Bikson M, George MS, Jenkins DD and Badran BW: Design and
validation of a closed-loop, motor-activated auricular vagus nerve
stimulation (MAAVNS) system for neurorehabilitation. Brain Stimul.
13:800–803. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
292
|
Badran BW, Peng X, Baker-Vogel B,
Hutchison S, Finetto P, Rishe K, Fortune A, Kitchens E, O'Leary GH,
Short A, et al: Motor activated auricular vagus nerve stimulation
as a potential neuromodulation approach for post-stroke motor
rehabilitation: A pilot study. Neurorehabil Neural Repair.
37:374–383. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
293
|
Yu Y, Ling J, Yu L, Liu P and Jiang M:
Closed-loop transcutaneous auricular vagal nerve stimulation:
Current situation and future possibilities. Front Hum Neurosci.
15:7856202022. View Article : Google Scholar : PubMed/NCBI
|
|
294
|
Forrest IS, Petrazzini BO, Duffy Á, Park
JK, Marquez-Luna C, Jordan DM, Rocheleau G, Cho JH, Rosenson RS,
Narula J, et al: Machine learning-based marker for coronary artery
disease: Derivation and validation in two longitudinal cohorts.
Lancet. 401:215–225. 2023. View Article : Google Scholar :
|
|
295
|
Upton R, Mumith A, Beqiri A, Parker A,
Hawkes W, Gao S, Porumb M, Sarwar R, Marques P, Markham D, et al:
Automated echocardiographic detection of severe coronary artery
disease using artificial intelligence. JACC Cardiovasc Imaging.
15:715–727. 2022. View Article : Google Scholar
|
|
296
|
Alizadehsani R, Abdar M, Roshanzamir M,
Khosravi A, Kebria PM, Khozeimeh F, Nahavandi S, Sarrafzadegan N
and Acharya UR: Machine learning-based coronary artery disease
diagnosis: A comprehensive review. Comput Biol Med. 111:1033462019.
View Article : Google Scholar : PubMed/NCBI
|
|
297
|
Obst MA, Al-Zubaidi A, Heldmann M, Nolde
JM, Blümel N, Kannenberg S and Münte TF: Five weeks of intermittent
transcutaneous vagus nerve stimulation shape neural networks: A
machine learning approach. Brain Imaging Behav. 16:1217–1233. 2022.
View Article : Google Scholar :
|
|
298
|
Tarasenko A, Guazzotti S, Minot T,
Oganesyan M and Vysokov N: Determination of the effects of
transcutaneous auricular vagus nerve stimulation on the heart rate
variability using a machine learning pipeline. Bioelectricity.
4:168–177. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
299
|
Chen H, Lai H, Chi H, Fan W, Huang J,
Zhang S, Jiang C, Jiang L, Hu Q, Yan X, et al: Multi-modal
transcriptomics: integrating machine learning and convolutional
neural networks to identify immune biomarkers in atherosclerosis.
Front Cardiovasc Med. 11:13974072024. View Article : Google Scholar : PubMed/NCBI
|
